Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Asian J Surg ; 41(6): 543-550, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29371051

RESUMO

BACKGROUND: This study aimed to analyze the effects of quercitrin, which has anti-inflammatory properties, on bacterial translocation in inflammatory bowel diseases by using an experimental colitis model. METHODS: Forty male Wistar-Albino rats were used in the study. Rats were divided into 4 groups (control, colitis, treatment 1 and 2 groups). The rats in the control group were given normal drinking water. In the colitis group, colitis was induced by 5% DSS in drinking water. The control and colitis groups underwent operation on Day 7. In the 2 treatment groups, 5% DSS was added to drinking water for the first 7 days and the groups were treated with quercitrin at the doses of 1 and 5 mg/kg/day for the following 10 days. Treatment groups operated on Day 18. Blood samples were taken for blood culture and left colectomy was performed. The inflammation in the colon was macroscopically and microscopically evaluated and graded. Tissue samples were taken (liver, spleen and mesenteric lymph nodes (MLN)) for tissue culturing in order to assess bacterial translocation. Tissue myeloperoxidase (MPO), serum tumor necrosis factor-alpha (TNF-α) and plasma endotoxin levels were measured. RESULTS: When the control and colitis groups were compared, observed that colitis was induced by DSS (p < 0.05). When the colitis and treatment groups were compared, it was found that quercitrin had a significant therapeutic effect (p < 0.05). CONCLUSION: In the experimental colitis model established by using DSS, treatment with quercitrin resulted in a histopathological improvement and reduction in biochemical parameters, inflammation and in bacterial translocation (p < 0.05).


Assuntos
Translocação Bacteriana/efeitos dos fármacos , Colite/microbiologia , Quercetina/análogos & derivados , Animais , Anti-Inflamatórios , Biomarcadores/análise , Biomarcadores/sangue , Colite/diagnóstico , Colite/tratamento farmacológico , Colite/patologia , Colo/patologia , Modelos Animais de Doenças , Endotoxinas/sangue , Inflamação/patologia , Masculino , Peroxidase/análise , Quercetina/farmacologia , Quercetina/uso terapêutico , Ratos , Fator de Necrose Tumoral alfa/sangue
2.
Breast Care (Basel) ; 9(2): 111-5, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24944554

RESUMO

BACKGROUND: Idiopathic granulomatous mastitis (IGM) is an uncommon chronic inflammatory disease of the breast with uncertain optimal treatment regimen. In this study, our purpose was to report our clinical experience with 74 IGM patients who were treated wide local excision with or without steroid therapy. PATIENTS AND METHOD: 74 cases diagnosed histologically as IGM were identified from surgical and pathological records between January 1995 and January 2012. Group 1 (surgery-only group) comprised 53 patients, and the 21 patients in group 2 were treated with corticosteroids prior to surgical treatment (steroid-and-surgery group). RESULTS: Follow-up data were complete for 67 (91.7%) of the 73 patients. Recurrence developed in 4 (7.5%) patients in the surgery-only group, while there was no recurrence in the steroid-and-surgery group; the difference was not statistically significant (p = 0.19). CONCLUSION: Systemic steroid therapy with surgical resection is the recommended first-line treatment strategy for IGM.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...